CU23842B1 - Derivados de n5-(2-etoxi-etil)-n3-(2-piridinil)-3,5-piperidin-dicarboxamida - Google Patents
Derivados de n5-(2-etoxi-etil)-n3-(2-piridinil)-3,5-piperidin-dicarboxamidaInfo
- Publication number
- CU23842B1 CU23842B1 CU2009000226A CU20090226A CU23842B1 CU 23842 B1 CU23842 B1 CU 23842B1 CU 2009000226 A CU2009000226 A CU 2009000226A CU 20090226 A CU20090226 A CU 20090226A CU 23842 B1 CU23842 B1 CU 23842B1
- Authority
- CU
- Cuba
- Prior art keywords
- compound
- treatment
- class
- dicarboxamida
- piridinil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
La presente invención se refiere a un compuesto de la fórmula I: ESPACIO PARA LA FÓRMULA en donde R1, R2, R3, R4 y R5 son como se definen en la memoria descriptiva, para utilizarse en el diagnóstico y el tratamiento terapéutico de un animal de sangre caliente, en especial para el tratamiento de una enfermedad (= trastorno) que dependa de la actividad de la renina; al uso de un compuesto de esta clase para la preparación de una formulación farmacéutica para el tratamiento de una enfermedad que dependa de la actividad de la renina; al uso de un compuesto de esta clase en el tratamiento de una enfermedad que dependa de la actividad de la renina; a formulaciones farmacéuticas de un compuesto de esta clase; a un método de tratamiento, el cual comprende administrar un compuesto de esta clase, y a un método para su fabricación.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07012412 | 2007-06-25 | ||
EP07111290 | 2007-06-28 | ||
PCT/EP2008/057964 WO2009000811A1 (en) | 2007-06-25 | 2008-06-23 | N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
CU20090226A7 CU20090226A7 (es) | 2012-02-15 |
CU23842B1 true CU23842B1 (es) | 2012-10-15 |
Family
ID=39926743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU2009000226A CU23842B1 (es) | 2007-06-25 | 2009-12-22 | Derivados de n5-(2-etoxi-etil)-n3-(2-piridinil)-3,5-piperidin-dicarboxamida |
Country Status (26)
Country | Link |
---|---|
US (2) | US8383650B2 (es) |
EP (2) | EP2181105B1 (es) |
JP (1) | JP5086433B2 (es) |
KR (1) | KR101238479B1 (es) |
CN (1) | CN101687847B (es) |
AR (1) | AR067132A1 (es) |
AU (1) | AU2008267287B2 (es) |
BR (1) | BRPI0813900A2 (es) |
CA (1) | CA2689109A1 (es) |
CL (1) | CL2008001872A1 (es) |
CO (1) | CO6251267A2 (es) |
CR (1) | CR11153A (es) |
CU (1) | CU23842B1 (es) |
EA (1) | EA016446B1 (es) |
EC (1) | ECSP099825A (es) |
ES (2) | ES2541107T3 (es) |
GT (1) | GT200900324A (es) |
HN (1) | HN2009003463A (es) |
IL (1) | IL202494A0 (es) |
MA (1) | MA31538B1 (es) |
NZ (1) | NZ582098A (es) |
PE (1) | PE20090425A1 (es) |
SG (1) | SG182223A1 (es) |
TN (1) | TN2009000530A1 (es) |
TW (1) | TWI404714B (es) |
WO (1) | WO2009000811A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2541107T3 (es) | 2007-06-25 | 2015-07-16 | Novartis Ag | Derivados de N5-(2-etoxietil)-N3-(2-piridinil)-3,5-piperidindicarboxamida para su uso como inhibidores de renina |
US20180048921A1 (en) * | 2016-08-12 | 2018-02-15 | Microsoft Technology Licensing, Llc | Real-time playback diagnostics |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2129679C (en) | 1991-12-18 | 2000-05-09 | Neng-Yang Shih | Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring |
IL111176A0 (en) | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them |
NZ315677A (en) | 1995-09-07 | 2000-02-28 | F | 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
CA2238081A1 (en) | 1995-11-22 | 1997-05-29 | S. Jane Desolms | Inhibitors of farnesyl-protein transferase |
JP2001526178A (ja) | 1997-08-28 | 2001-12-18 | メルク エンド カムパニー インコーポレーテッド | ピロリジン系およびピペリジン系ケモカイン受容体活性調節剤 |
EP1087937A1 (en) | 1998-06-17 | 2001-04-04 | Du Pont Pharmaceuticals Company | Cyclic hydroxamic acids as metalloproteinase inhibitors |
US6274735B1 (en) | 1998-08-10 | 2001-08-14 | Hoffmann-La Roche Inc. | Process and intermediates for preparation of substituted piperidines |
US6610692B1 (en) | 1998-10-30 | 2003-08-26 | Merck & Co., Inc. | Thrombin inhibitors |
AU3389300A (en) | 1999-03-02 | 2000-09-21 | Merck & Co., Inc. | Pyrrolidine modulators of chemokine receptor activity |
AU3386700A (en) | 1999-03-02 | 2000-09-21 | Merck & Co., Inc. | 3-thienyl and 3-furanyl pyrrolidine modulators of chemokine receptor activity |
US6362201B1 (en) | 1999-03-02 | 2002-03-26 | Merck & Co., Inc. | 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity |
WO2000063173A1 (en) | 1999-04-14 | 2000-10-26 | F. Hoffmann-La Roche Ag | Process for the preparation of substituted piperidines |
US6197959B1 (en) | 1999-04-27 | 2001-03-06 | Hoffmann-La Roche Inc. | Piperidine derivatives |
US6376672B1 (en) | 1999-04-27 | 2002-04-23 | Hoffmann-La Roche Inc. | Naphthalenylmethoxypiperidines as renin inhibitors |
BR0109467A (pt) | 2000-03-17 | 2003-06-03 | Bristol Myers Squibb Pharma Co | Composto derivados de (beta)-aminoácidos cìclicos, composição farmacêutica, método de tratamento de condições ou doenças mediadas por mps, tnf, aggrecanase ou uma combinação destes em mamìferos e uso de composto |
FR2811673B1 (fr) | 2000-07-17 | 2002-09-13 | Rhodia Chimie Sa | Utilisation de composes insatures comprenant un heterocycle comme stabilisants de polymeres halogenes |
EP1326619A2 (en) | 2000-10-11 | 2003-07-16 | Merck & Co., Inc. | Pyrrolidine modulators of ccr5 chemokine receptor activity |
WO2002076440A2 (en) | 2001-03-23 | 2002-10-03 | Elan Pharmaceuticals, Inc. | Methods of treating alzheimer's disease with piperidin derivates |
EP1389194A2 (en) | 2001-04-27 | 2004-02-18 | Vertex Pharmaceuticals Incorporated | Inhibitors of bace |
WO2003024899A2 (en) | 2001-09-17 | 2003-03-27 | Bristol-Myers Squibb Company | CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
WO2003031443A1 (en) | 2001-10-04 | 2003-04-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
CA2483241C (en) | 2002-04-29 | 2011-05-31 | Actelion Pharmaceuticals Ltd | Novel diazabicyclononene derivatives |
ES2315568T3 (es) | 2002-05-20 | 2009-04-01 | Bristol-Myers Squibb Company | Inhibidores del virus de la hepatitis c basados en cicloalquilo p1' sustituido. |
PL374860A1 (en) | 2002-07-09 | 2005-11-14 | Bristol-Myers Squibb Company | Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
US20040214832A1 (en) | 2003-04-10 | 2004-10-28 | Cuiman Cai | Piperazine derivative renin inhibitors |
US20040204455A1 (en) | 2003-04-10 | 2004-10-14 | Cody Wayne Livingston | Piperidine derivative rennin inhibitors |
US20060217371A1 (en) | 2003-04-28 | 2006-09-28 | Olivier Bezencon | Diazabicyclononene and tetrahydropyriddine derivatives as renin inhibitors |
AU2004234039A1 (en) | 2003-04-29 | 2004-11-11 | Actelion Pharmaceuticals Ltd | Novel 3,4-disubstituted 1,2,3,6-tetrahydropyridine derivatives |
US20060205768A1 (en) | 2003-04-30 | 2006-09-14 | Olivier Bezencon | Tropane derivatives and their use as ace inhibitors |
EP1622685A1 (en) | 2003-04-30 | 2006-02-08 | Actelion Pharmaceuticals Ltd. | 9-azabicyclo[3.3.1]non-6-ene derivatives with a heteroatom at the 3-position as renin inhibitors |
JP2006524654A (ja) | 2003-04-30 | 2006-11-02 | アクテリオン ファマシューティカルズ リミテッド | 新規アザビシクロノネン誘導体 |
KR20060015573A (ko) | 2003-05-02 | 2006-02-17 | 액테리온 파마슈티칼 리미티드 | 신규한 디아자비시클로노넨 유도체 |
US7144907B2 (en) | 2003-09-03 | 2006-12-05 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
TW200513461A (en) | 2003-10-01 | 2005-04-16 | Speedel Experimenta Ag | Organische verbindungen |
WO2005040120A1 (en) | 2003-10-09 | 2005-05-06 | Actelion Pharmaceuticals Ltd | Tetrahydropyridine derivatives |
RU2374228C2 (ru) | 2003-11-26 | 2009-11-27 | Новартис Аг | Производные 4-фенилпиперидина в качестве ингибиторов ренина |
US7582782B2 (en) | 2003-11-26 | 2009-09-01 | Novartis Ag | Organic compounds |
WO2005070871A2 (en) | 2004-01-23 | 2005-08-04 | Speedel Experimenta Ag | Amino alcohol derivatives and their activity as renin inhibitors |
DE602005022060D1 (de) | 2004-01-23 | 2010-08-12 | Novartis Ag | Diaminoalkohole und deren verwendung als renininhibitoren |
JP2007518777A (ja) | 2004-01-23 | 2007-07-12 | シュペーデル・エクスペリメンタ・アーゲー | アミノアルコール誘導体およびレニン阻害剤としてのその使用 |
TW200609215A (en) | 2004-03-19 | 2006-03-16 | Speedel Experimenta Ag | Organic compounds |
DE602005012481D1 (de) | 2004-03-19 | 2009-03-12 | Speedel Experimenta Ag | 2,7-substituierte 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octanamid derivate als renin inhibitoren zur behandlung von bluthochdruck |
AR053406A1 (es) | 2004-07-09 | 2007-05-09 | Speedel Experimenta Ag | Derivados de piperidina como inhibidores de renina. composiciones farmaceuticas |
TW200631929A (en) | 2004-12-10 | 2006-09-16 | Speedel Experimenta Ag | ω -phenyloctanamides |
GB0428250D0 (en) | 2004-12-23 | 2005-01-26 | Novartis Ag | Organic compounds |
GB0428526D0 (en) | 2004-12-30 | 2005-02-09 | Novartis Ag | Organic compounds |
GB0500784D0 (en) | 2005-01-14 | 2005-02-23 | Novartis Ag | Organic compounds |
GB0504850D0 (en) | 2005-03-09 | 2005-04-13 | Novartis Ag | Organic compounds |
JP2008532983A (ja) | 2005-03-11 | 2008-08-21 | シュペーデル・エクスペリメンタ・アーゲー | レニン阻害剤として有用な複素環置換アルカンアミド |
GB0505969D0 (en) | 2005-03-23 | 2005-04-27 | Novartis Ag | Organic compounds |
TW200722424A (en) | 2005-03-31 | 2007-06-16 | Speedel Experimenta Ag | Substituted piperidines |
BRPI0609534A2 (pt) | 2005-03-31 | 2010-04-13 | Speedel Experimenta Ag | piperidinas 3,4,5-substituìdas |
GB0508992D0 (en) * | 2005-05-03 | 2005-06-08 | Novartis Ag | Organic compounds |
GB0510810D0 (en) | 2005-05-26 | 2005-06-29 | Novartis Ag | Organic compounds |
GB0511063D0 (en) | 2005-05-31 | 2005-07-06 | Novartis Ag | Organic compounds |
GB0514203D0 (en) * | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
EP1937248B1 (en) | 2005-09-17 | 2010-06-02 | Novartis Ag | Alcanoic acid amides substituted by saturated o-heterocycles |
CA2622082A1 (en) | 2005-09-17 | 2007-03-22 | Speedel Experimenta Ag | 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
PE20071079A1 (es) * | 2005-11-15 | 2007-12-16 | Cytokinetics Inc | Compuestos de piperidina como inhibidores de la proliferacion celular |
ES2430139T3 (es) * | 2005-12-30 | 2013-11-19 | Novartis Ag | Compuestos de piperidina 3,5-sustituido como inhibidores de renina |
EP1816122A3 (en) * | 2006-01-19 | 2007-09-19 | Speedel Experimenta AG | 3,4,5-substituted piperidines as therapeutic compounds |
JP2009525304A (ja) | 2006-01-30 | 2009-07-09 | シュペーデル・エクスペリメンタ・アーゲー | α,β−不飽和化合物からのアルコールの立体選択的製造方法 |
BRPI0712430A2 (pt) | 2006-06-08 | 2012-07-03 | Speedel Experimenta Ag | piperidinas 2,5-di-substitìdas. |
GB0611696D0 (en) | 2006-06-13 | 2006-07-26 | Novartis Ag | Organic compounds |
GB0611697D0 (en) | 2006-06-13 | 2006-07-26 | Novartis Ag | Organic compounds |
TW200831463A (en) | 2006-09-12 | 2008-08-01 | Speedel Experimenta Ag | Nitrate esters of aminoalcohols |
EP1908471A1 (en) | 2006-10-04 | 2008-04-09 | Speedel Experimenta AG | Tetrahydropyridines as renin inhibitors |
EP1921069A1 (de) | 2006-11-08 | 2008-05-14 | Speedel Experimenta AG | Verfahren zur Herstellung von 2-Alkyl-3-heterocyclyl-prop-2-en-1-olen |
WO2008113835A1 (en) | 2007-03-21 | 2008-09-25 | Novartis Ag | Process for preparing (r or s)-5-{1-azido-3-[6-methoxy-5-(3-methoxy-propoxy)-pyridin-3-ylmethyl]-4-methyl-pentyl}-3-alkyl-dihydro-furan-2-one |
ES2541107T3 (es) | 2007-06-25 | 2015-07-16 | Novartis Ag | Derivados de N5-(2-etoxietil)-N3-(2-piridinil)-3,5-piperidindicarboxamida para su uso como inhibidores de renina |
-
2008
- 2008-06-23 ES ES08761309.7T patent/ES2541107T3/es active Active
- 2008-06-23 SG SG2012046132A patent/SG182223A1/en unknown
- 2008-06-23 AU AU2008267287A patent/AU2008267287B2/en not_active Ceased
- 2008-06-23 ES ES12176689.3T patent/ES2543641T3/es active Active
- 2008-06-23 BR BRPI0813900-8A2A patent/BRPI0813900A2/pt not_active IP Right Cessation
- 2008-06-23 EP EP08761309.7A patent/EP2181105B1/en active Active
- 2008-06-23 EA EA201000037A patent/EA016446B1/ru not_active IP Right Cessation
- 2008-06-23 AR ARP080102691A patent/AR067132A1/es not_active Application Discontinuation
- 2008-06-23 CA CA002689109A patent/CA2689109A1/en not_active Abandoned
- 2008-06-23 EP EP20120176689 patent/EP2527338B1/en active Active
- 2008-06-23 JP JP2010513876A patent/JP5086433B2/ja not_active Expired - Fee Related
- 2008-06-23 CN CN2008800218979A patent/CN101687847B/zh not_active Expired - Fee Related
- 2008-06-23 WO PCT/EP2008/057964 patent/WO2009000811A1/en active Application Filing
- 2008-06-23 KR KR1020097027047A patent/KR101238479B1/ko not_active IP Right Cessation
- 2008-06-23 NZ NZ582098A patent/NZ582098A/en not_active IP Right Cessation
- 2008-06-24 CL CL2008001872A patent/CL2008001872A1/es unknown
- 2008-06-24 PE PE2008001078A patent/PE20090425A1/es not_active Application Discontinuation
- 2008-06-24 TW TW097123556A patent/TWI404714B/zh not_active IP Right Cessation
- 2008-06-25 US US12/146,073 patent/US8383650B2/en not_active Expired - Fee Related
-
2009
- 2009-12-03 IL IL202494A patent/IL202494A0/en unknown
- 2009-12-09 CR CR11153A patent/CR11153A/es unknown
- 2009-12-17 TN TNP2009000530A patent/TN2009000530A1/fr unknown
- 2009-12-18 GT GT200900324A patent/GT200900324A/es unknown
- 2009-12-22 HN HN2009003463A patent/HN2009003463A/es unknown
- 2009-12-22 CO CO09146659A patent/CO6251267A2/es active IP Right Grant
- 2009-12-22 CU CU2009000226A patent/CU23842B1/es not_active IP Right Cessation
- 2009-12-23 EC EC2009009825A patent/ECSP099825A/es unknown
-
2010
- 2010-01-22 MA MA32543A patent/MA31538B1/fr unknown
-
2012
- 2012-09-14 US US13/616,081 patent/US8497286B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088587A (es) | Compuestos de piperidina 3,5-sustituida como inhibidores de renina | |
ECSP11011113A (es) | Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades | |
MX2007011009A (es) | Compuestos de piperidina 3,4,5-substituidos. | |
UY29562A1 (es) | Compuestos heterocíclicos de amino benzoilo, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
CO6300957A2 (es) | Derivados de imidazo -[1,2,b]-piridazina para el tratamiento de enfermedad mediada por cinasa de tirosina c-met | |
CU20110221A7 (es) | Derivados de 1h-imidazo-[4,5-c]-quinolinona | |
GT200500359A (es) | Compuestos organicos | |
BRPI0519443A2 (pt) | composto orgÂnicos | |
ECSP099409A (es) | Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona, procedimientos para su preparación y su uso como agentes farmacéuticos | |
CR9749A (es) | Derivados de xantina como agonistas de hm74a selectivos | |
CL2007003289A1 (es) | Compuestos derivados de biciclocarboxiamida; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades provocadas por la hiperactivacion del receptor vc1 como dolor, enfermedad de vejiga, inflam | |
UY30419A1 (es) | Nuevos benzoxazoles heteroaril sustituidos | |
ECSP10010694A (es) | DERIVADOS DE BENZOXAZINONA QUE ACTÚAN COMO AGONISTAS DE RECEPTORES ADRENÉRGICOS ß2 PARA EL TRATAMIENTO DE TRASTORNOS RESPIRATORIOS | |
GT200500328A (es) | Sal l-tartrato de n-1-adamantil-2-{3-[(2r)-2-({(2r)-2-hidroxi-2[4-hidroxi-3-(hidroximetil)fenil]etil}amino)propil]fenil}acetamida. | |
CU20120081A7 (es) | Nuevas formas polimorfas de {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}carbamato de metilo | |
WO2010051196A8 (en) | Novel substituted azabenzoxazoles | |
CU20090226A7 (es) | Derivados de n5-(2-etoxi-etil)-n3-(2-piridinil)-3,5-piperidin-dicarboxamida | |
CO6290762A2 (es) | Nuevos derivados quinazolin-2, 4-diona y una composicion farmaceutica para prevenir a tratar la enfermedad neurocerebral | |
WO2009114136A3 (en) | Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents | |
BRPI0606750A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, e,composição farmacêutica | |
UY29832A1 (es) | Derivados de 2-aminotiazoles y 2-aminooxazoles, procesos para su preparación y su uso como compuestos farmacéuticos. | |
WO2007144129A3 (en) | Pyrrolidine derivatives useful against diseases that depends on activity of renin | |
UA99461C2 (en) | N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors | |
ECSP066772A (es) | Compuestos de pirazolina sustituidos para reducir trigliceridos en la sangre | |
UY28208A1 (es) | Derivados cicloalquilo que tienen grupos acido carboxilico bioisostéricos, procesos para su preparación y su uso como composiciones farmaceuticas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant of patent | ||
FD | Lapse (for not paying fees) |